BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33244329)

  • 21. Strengthening immunization in a West African country: Mali.
    Milstien JB; Tapia M; Sow SO; Keita L; Kotloff K
    Educ Health (Abingdon); 2007 Nov; 20(3):120. PubMed ID: 18080961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The decision making process on new vaccines introduction in South Africa.
    Ngcobo NJ; Cameron NA
    Vaccine; 2012 Sep; 30 Suppl 3():C9-13. PubMed ID: 22939028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direction of National Vaccine Program and role of adverse events following immunization.
    Win S
    Southeast Asian J Trop Med Public Health; 2014; 45 Suppl 1():40-2. PubMed ID: 25423787
    [No Abstract]   [Full Text] [Related]  

  • 24. From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project.
    Aguado MT; Jodar L; Granoff D; Rabinovich R; Ceccarini C; Perkin GW
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S391-5. PubMed ID: 26553665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The future of routine immunization in Africa.
    Kamadjeu R
    Pan Afr Med J; 2017; 27(Suppl 3):1. PubMed ID: 29296136
    [No Abstract]   [Full Text] [Related]  

  • 26. Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme.
    Madhi SA; Bamford L; Ngcobo N
    S Afr Med J; 2014 Mar; 104(3 Suppl 1):228-34. PubMed ID: 24893498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adolescent vaccination: recommendations from the National Vaccine Advisory Committee.
    ; Stokley S; Freed G; Curtis R; Gordon L; Humiston S; Parnell T; Pavia A; Young A; Johnson D; Kennedy A; Hopfensperger D; Markowitz L; Fergie J; Koslap-Petraco MB; McCauley M
    Am J Prev Med; 2009 Mar; 36(3):278-9.e6. PubMed ID: 19162432
    [No Abstract]   [Full Text] [Related]  

  • 28. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
    Abdullahi LH; Hussey GD; Wiysonge CS; Kagina BM
    S Afr Med J; 2020 May; 110(6):525-531. PubMed ID: 32880566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination planning in Italy: increasing vaccines while reducing coverage?
    Garattini L; Curto A; Freemantle N
    Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):547-548. PubMed ID: 27441592
    [No Abstract]   [Full Text] [Related]  

  • 30. The challenge of improving immunization coverage: the New Zealand example.
    Turner N
    Expert Rev Vaccines; 2012 Jan; 11(1):9-11. PubMed ID: 22149701
    [No Abstract]   [Full Text] [Related]  

  • 31. SMS-reminder for vaccination in Africa: research from published, unpublished and grey literature.
    Manakongtreecheep K
    Pan Afr Med J; 2017; 27(Suppl 3):23. PubMed ID: 29296158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Putting prevention research at risk: implementation of the Vaccines for Children programme.
    Saldarini RJ
    Vaccine; 1994 Nov; 12(15):1364-7. PubMed ID: 7887011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Over a Third of Young Children in Michigan Are Susceptible to Vaccine Preventable Diseases.
    Bramer C
    Mich Med; 2016; 115(2):8-9. PubMed ID: 27149752
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination vaccines in the South African setting.
    Visser A; Hoosen A
    Vaccine; 2012 Sep; 30 Suppl 3():C38-44. PubMed ID: 22939020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccines have sex differential non-targeted heterologous effects: a new dawn in vaccine research.
    Flanagan KL
    Trans R Soc Trop Med Hyg; 2015 Jan; 109(1):1-2. PubMed ID: 25573102
    [No Abstract]   [Full Text] [Related]  

  • 36. Recent advances in veterinary applications of structural vaccinology.
    Charleston B; Graham SP
    Curr Opin Virol; 2018 Apr; 29():33-38. PubMed ID: 29550741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies for decision-making on vaccine use: the French experience.
    Loulergue P; Floret D; Launay O
    Expert Rev Vaccines; 2015 Jul; 14(7):917-22. PubMed ID: 25913015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An African plan to control COVID-19 is urgently needed.
    The Lancet
    Lancet; 2020 Dec; 396(10265):1777. PubMed ID: 33278920
    [No Abstract]   [Full Text] [Related]  

  • 39. Expanding the reach of vaccinology training in Africa: leveraging the success of the Annual African Vaccinology Course.
    Manga N; Amponsah-Dacosta E; Hussey G; Muloiwa R; Kagina BM
    Front Health Serv; 2023; 3():1119858. PubMed ID: 37727323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy.
    Madhi SA; Cohen C; von Gottberg A
    Vaccine; 2012 Sep; 30 Suppl 3():C21-7. PubMed ID: 22939016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.